Literature DB >> 7951929

Natural history of nonarteritic anterior ischemic optic neuropathy.

A C Arnold1, R S Hepler.   

Abstract

Visual acuity and quantitative perimetry (Octopus Program 32) testing was performed in the acute (< 30 days after onset) and convalescent (> 3 months after onset) phases of disease in 27 patients with untreated NAION. Initial group mean acuity and sensitivity loss were compared to final values using the t test. Proportions of patients demonstrating a change of > 2 lines acuity or > 2 dB mean sensitivity were calculated. Patients were classified as either "progressive" (n = 6) or "stable" (n = 21) for purposes of additional subgroup analysis. There was no significant change in group mean visual acuity or field over time. Overall, significant worsening occurred in 11.1% for visual acuity and 22.2% for visual field; improvement occurred in 23.8% for acuity and 24.0% for field. Of 21 "stable" patients, none worsened for acuity and 4.7% showed late worsening of field; 31.3% showed significant improvement for acuity and 31.6% for field. No "progressive" patients demonstrated worsening or improvement after the initial progressive phase.

Entities:  

Mesh:

Year:  1994        PMID: 7951929

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  18 in total

Review 1.  Ocular vascular occlusive disorders: natural history of visual outcome.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2014-04-21       Impact factor: 21.198

2.  Application of HELP in nonarteritic anterior ischemic optic neuropathy: a prospective, randomized, controlled study.

Authors:  A Haas; M Walzl; F Jesenik; B Walzl; A Berghold; J Berglöff; B Feigl; J Faulborn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

3.  Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy.

Authors:  C Yu; J K Ho; Y J Liao
Journal:  Eye (Lond)       Date:  2014-09-26       Impact factor: 3.775

Review 4.  Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models.

Authors:  Steven L Bernstein; Mary A Johnson; Neil R Miller
Journal:  Prog Retin Eye Res       Date:  2011-03-02       Impact factor: 21.198

5.  Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.

Authors:  Steven E Feldon
Journal:  Trans Am Ophthalmol Soc       Date:  2004

6.  Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients.

Authors:  Dimitrios Brouzas; Antonios Charakidas; Ioannis Ladas; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Clinical approach to optic neuropathies.

Authors:  Raed Behbehani
Journal:  Clin Ophthalmol       Date:  2007-09

8.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

9.  Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time.

Authors:  Roberta W Scherer; Steven E Feldon; Lori Levin; Patricia Langenberg; Joanne Katz; Penelope M Keyl; P David Wilson; Shalom E Kelman; Kay Dickersin
Journal:  Ophthalmology       Date:  2008-05-16       Impact factor: 12.079

10.  Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.